Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit Guide
2026-08-18
Build bright, customizable RNA probes for in situ hybridization and Northern blot workflows with tunable Cy3-UTP incorporation. This practical guide connects probe design and troubleshooting to the MALAT1/miR-125b/STAT3 sepsis study while distinguishing published findings from workflow recommendations.
-
Nifedipine Research Workflows: Calcium & PXR
2026-08-18
Nifedipine (BAY-a-1040) provides a controllable L-type calcium influx perturbation for cardiac, iron-transport, hepatic, and pathogen assays. This guide translates the reference study’s PXR and CYP findings into practical comparison workflows while clearly separating calcium-channel effects from direct nuclear-receptor activation.
-
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-08-17
A 2024 Nature Communications study identifies the spliceosomal protein SmD2 as an acetylation-regulated determinant of BRCA1/FANC cassette-exon expression and PARP inhibitor sensitivity in hepatocellular carcinoma. The findings connect core spliceosome regulation with DNA damage repair and support combining HDAC inhibition with PARP inhibition in selected HCC models.
-
IWP-2 Workflows for Wnt Production Inhibition
2026-08-17
IWP-2 enables upstream Porcn blockade for studying Wnt-dependent proliferation, invasion, and apoptosis in gastric cancer models. This practical guide also shows how to adapt the inhibitor into cell-type-resolved developmental assays without overstating evidence from neurodevelopmental research.
-
LDN-193189: Mapping BMP Signals in Cell Plasticity
2026-08-16
Explore how LDN-193189, a selective ALK inhibitor, can separate BMP receptor signaling from TGF-β-driven epithelial plasticity. This article translates mechanistic evidence into assay strategies for stem-cell, barrier, and heterotopic ossification research.
-
2-Hydroxypropyl-β-cyclodextrin Protocol Guide
2026-08-15
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide solubilizer for screening poorly water-soluble hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. It is best used as a drug formulation excipient or pharmaceutical solubility improvement aid; the available dossier does not establish therapeutic efficacy or applications outside solubility-focused pharmaceutical and biochemical workflows.
-
Prenatal Nanoplastics Rewire Vascular Lipid Homeostasis
2026-08-14
A 2026 Cardiovascular Toxicology study shows that prenatal and lactational exposure to polystyrene nanoplastics promotes lipid accumulation in the aortic smooth muscle of male offspring through an MAPK/ERK/UHRF1 axis. The work combines an early-life mouse exposure model with MOVAS-cell experiments, ERK inhibition, and UHRF1 knockdown to connect developmental exposure with vascular lipid dysregulation.
-
Two Flavone 2′-Glucosides from Scutellaria baicalensis
2026-08-14
Ishimaru and colleagues isolated two previously undescribed flavone 2′-O-glucosides from Scutellaria baicalensis roots and established their structures through chromatography, mass spectrometry, UV, and NMR analysis. The study also documented baicalin methyl ester, an esterified derivative of baicalin, within a broader phenolic profile, providing an important natural-products reference for subsequent intestinal inflammation research.
-
Trolox Workflows for Oxidative Stress Assays
2026-08-13
Trolox provides a practical antioxidant benchmark for cell-free assays, oxidative injury models, and redox-sensitive organoid experiments. This guide shows how to prepare, deploy, and troubleshoot 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid without confusing antioxidant rescue with improved organoid growth or disease-specific efficacy.
-
10058-F4: c-Myc-Max Dimerization Inhibitor
2026-08-13
Use 10058-F4 to connect c-Myc/Max disruption with transcriptional, chromatin, viability, apoptosis, and differentiation readouts. This workflow also translates recent TERT findings in human pluripotent stem cells into practical assay designs while keeping formulation and model-specific limitations visible.
-
TUNEL Apoptosis Detection Kit: Practical Workflows
2026-08-12
Translate DNA fragmentation into a clear brown signal with a DAB-based TUNEL assay for tissue sections and cultured cells. This workflow guide connects oxidative-stress biology, assay controls, image interpretation, and troubleshooting for reproducible programmed cell death research.
-
ABT-263 and the Next Logic of Apoptosis Translation
2026-08-12
A mechanistic and translational framework for using ABT-263 (Navitoclax) to connect Bcl-2 family dependence, mitochondrial priming, caspase activation, and emerging insights into Pol II-linked cell death.
-
Ginsenosides and High-Altitude Hypoxia Injury
2026-08-11
Ji et al. investigated how ginsenosides protect rat lung and kidney tissues during simulated high-altitude hypoxia, linking the response to PHD2/HIF-1α/EPO signaling. The study combines physiological, histological, biochemical, inflammatory, oxidative-stress, and protein-localization measurements to support a multi-level protective mechanism.
-
Parathyroid hormone (1-34) (human) Research Guide
2026-08-11
Parathyroid hormone (1-34) (human) is a biologically active PTH (1-34) peptide fragment used to study PTH/PTHrP receptor signaling, calcium homeostasis, and bone remodeling. Product benchmarks include nanomolar receptor activity and dose-dependent bone-mass responses in male Fisher 344 rats.
-
Alfuzosin HCl: Receptor Biology to Retention
2026-08-10
Alfuzosin HCl connects α1-adrenoceptor pharmacology with gastroretentive formulation science. This evidence-led guide explains how receptor readouts, analytical controls, and MRI-verified retention can improve benign prostatic hyperplasia research decisions.